Ledipasvir/Sofosbuvir fixed-dose combination
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Ledipasvir/Sofosbuvir fixed-dose combination, covering 2016-01-14 to 2019-08-20. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed Dose Combination in the Treatment of Hepatitis C Virus (HCV) Infection in Pediatric Participants Undergoing Cancer Chemotherapy [Phase 2]